Your browser doesn't support javascript.
loading
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.
Siegel, Michel; Steiner, Guido; Franssen, Linnea C; Carratu, Francesca; Herron, James; Hartman, Katharina; Looney, Cary M; Ducret, Axel; Bray-French, Katharine; Rohr, Olivier; Hickling, Timothy P; Smith, Noel; Marban-Doran, Céline.
  • Siegel M; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Steiner G; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Franssen LC; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Carratu F; Lonza Biologics, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
  • Herron J; Lonza Biologics, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
  • Hartman K; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Looney CM; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Ducret A; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Bray-French K; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Rohr O; UR 7292, IUT Louis Pasteur, Université de Strasbourg, 67300 Schiltigheim, France.
  • Hickling TP; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
  • Smith N; Lonza Biologics, Chesterford Research Park, Saffron Walden CB10 1XL, UK.
  • Marban-Doran C; Roche Pharmaceutical Research and Early Development, Pharmaceutical Sciences, Roche Innovation Center Basel, 4070 Basel, Switzerland.
Pharmaceutics ; 14(12)2022 Dec 01.
Article en En | MEDLINE | ID: mdl-36559166

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Año: 2022 Tipo del documento: Article